Literature DB >> 10393889

Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions.

D J Mayer1, J Mao, J Holt, D D Price.   

Abstract

Compelling evidence has accumulated over the last several years from our laboratory, as well as others, indicating that central hyperactive states resulting from neuronal plastic changes within the spinal cord play a critical role in hyperalgesia associated with nerve injury and inflammation. In our laboratory, chronic constriction injury of the common sciatic nerve, a rat model of neuropathic pain, has been shown to result in activation of central nervous system excitatory amino acid receptors and subsequent intracellular cascades including protein kinase C translocation and activation, nitric oxide production, and nitric oxide-activated poly(ADP ribose) synthetase activation. Similar cellular mechanisms also have been implicated in the development of tolerance to the analgesic effects of morphine. A recently observed phenomenon, the development of "dark neurons," is associated with both chronic constriction injury and morphine tolerance. A site of action involved in both hyperalgesia and morphine tolerance is in the superficial laminae of the spinal cord dorsal horn. These observations suggest that hyperalgesia and morphine tolerance may be interrelated at the level of the superficial laminae of the dorsal horn by common neural substrates that interact at the level of excitatory amino acid receptor activation and subsequent intracellular events. The demonstration of interrelationships between neural mechanisms underlying hyperalgesia and morphine tolerance may lead to a better understanding of the neurobiology of these two phenomena in particular and pain in general. This knowledge may also provide a scientific basis for improved pain management with opiate analgesics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10393889      PMCID: PMC33610          DOI: 10.1073/pnas.96.14.7731

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  NG-nitro-L-arginine prevents morphine tolerance.

Authors:  Y A Kolesnikov; C G Pick; G W Pasternak
Journal:  Eur J Pharmacol       Date:  1992-10-20       Impact factor: 4.432

2.  The effect of phorbol esters on the responses of primate spinothalamic neurons to mechanical and thermal stimuli.

Authors:  J Palecek; V Palecková; P M Dougherty; W D Willis
Journal:  J Neurophysiol       Date:  1994-02       Impact factor: 2.714

3.  Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity.

Authors:  J Zhang; V L Dawson; T M Dawson; S H Snyder
Journal:  Science       Date:  1994-02-04       Impact factor: 47.728

4.  Generation of superoxide by purified brain nitric oxide synthase.

Authors:  S Pou; W S Pou; D S Bredt; S H Snyder; G M Rosen
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

5.  Involvement of nitric oxide in spinally mediated hyperalgesia in the mouse.

Authors:  K F Kitto; J E Haley; G L Wilcox
Journal:  Neurosci Lett       Date:  1992-12-14       Impact factor: 3.046

6.  Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat.

Authors:  M Tal; G J Bennett
Journal:  Neurosci Lett       Date:  1993-03-05       Impact factor: 3.046

7.  Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy.

Authors:  J Mao; D D Price; R L Hayes; J Lu; D J Mayer; H Frenk
Journal:  Brain Res       Date:  1993-03-05       Impact factor: 3.252

8.  Patterns of increased brain activity indicative of pain in a rat model of peripheral mononeuropathy.

Authors:  J Mao; D J Mayer; D D Price
Journal:  J Neurosci       Date:  1993-06       Impact factor: 6.167

9.  Spatial patterns of increased spinal cord membrane-bound protein kinase C and their relation to increases in 14C-2-deoxyglucose metabolic activity in rats with painful peripheral mononeuropathy.

Authors:  J Mao; D J Mayer; R L Hayes; D D Price
Journal:  J Neurophysiol       Date:  1993-08       Impact factor: 2.714

10.  Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel.

Authors:  Y Chen; L Yu
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  101 in total

Review 1.  The neurobiology of pain.

Authors:  R Dubner; M Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 2.  NO as a signalling molecule in the nervous system.

Authors:  Juan V Esplugues
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

3.  Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats.

Authors:  Dong Zhou; Meng-Ling Chen; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

Review 4.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

5.  NO-ergic neurons of the cervical nucleus of the rat brain in normal conditions and after administration of opiates.

Authors:  I V Dyuizen; I I Deridovich; R A Kurbatskii; V V Shorin
Journal:  Neurosci Behav Physiol       Date:  2004-07

Review 6.  [Do opioids induce hyperalgesia?].

Authors:  C Zöllner
Journal:  Anaesthesist       Date:  2010-11       Impact factor: 1.041

7.  Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids.

Authors:  Linda R Watkins; Mark R Hutchinson; Annemarie Ledeboer; Julie Wieseler-Frank; Erin D Milligan; Steven F Maier
Journal:  Brain Behav Immun       Date:  2006-12-18       Impact factor: 7.217

8.  Morphine enhances microglial migration through modulation of P2X4 receptor signaling.

Authors:  Ryan J Horvath; Joyce A DeLeo
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.

Authors:  Ian A Mendez; Keith A Trujillo
Journal:  Psychopharmacology (Berl)       Date:  2007-11-10       Impact factor: 4.530

10.  Reduced cold pain tolerance in chronic pain patients following opioid detoxification.

Authors:  Jarred Younger; Peter Barelka; Ian Carroll; Kim Kaplan; Larry Chu; Ravi Prasad; Ray Gaeta; Sean Mackey
Journal:  Pain Med       Date:  2008-06-18       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.